In order to achieve these goals, five focal areas were structured and world experts with experience in the five areas were recruited. The working group will consist of one core group that will prepare and draft the strategic plan, as well as a review group that will support the core group (See Figure above).

Core Group

  • Gabriel Alcoba (Hôpitaux Universitaires de Genève, Geneva, Switzerland)
  • Jean-Phillippe Chippaux (Institut de Recherche pour le Développement Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France)
  • Delese Mimi Darko (Food and Drug Authority, Accra, Ghana)
  • Abul Faiz (Previously Bangladesh Association for the Advancement of Tropical Medicine, Chittagong, Bangladesh)
  • Hui Wen Fan (Instituto Butantan, Sâo Paulo, Brazil)
  • Christeine Ariaranee Gnanathasan (University of Colombo, Colombo, Sri Lanka)
  • Abdulrazaq G Habib (College of Health Sciences, Bayero University Kano, Nigeria)
  • Robert Harrison (Liverpool School of Tropical Medicine, Liverpool, United Kingdom)
  • Thomas Junghanss (Heidelberg University, Heidelberg, Germany)
  • Fatima Laraba-Djebari (University of Sciences and Technology Houari Boumediene, Alger, Algeria)
  • Kavi Ratanabanangkoon (Mahidol University, Bangkok, Thailand)
  • Charles Michael Robertson Turner (The Wellcome Trust, London, United Kingdom)
  • Benjamin Waldmann (Health Action International, Amsterdam, Netherlands)
  • David Warrell (University of Oxford, Oxford, United Kingdom)
  • David John Williams (University of Melbourne, Melbourne, Australia)

Review Group

  • Edward Abwao (Pharmacy and Poisons Board, Nairobi, Kenya)
  • Zuhair Amr (Jordan University of Science and Technology, Irbid, Jordan)
  • Denny John (Campbell Collaboration, New Delhi, India)
  • Priyanka Kadam (Snakebite Healing and Education Society, Mumbai, India)
  • Ahmad Khaldun Ismail (Hospital Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia)
  • David Lalloo (Liverpool School of Tropical Medicine, Liverpool, United Kingdom)
  • Andreas Hougaard Lausten (Technical University of Denmark, Lyngby, Denmark)
  • Matthew Lewin (California Academy of Sciences, San Francisco, United States of America)
  • Thea Litschka-Koen (Lubombo Management Services, Simunye, Swaziland)
  • Tri Maharani (Dungus Lung Hospital, Raya Dungus, Indonesia)
  • Leonardo José León Nuñez (Instituto Nacional de Salud, Bogotá, Colombia)
  • Sanjib Sharma (B.P. Koirala Institute of Health Sciences, Dharan, Nepal)
  • Nget Hong Tan (University of Malaya, Kuala Lumpur, Malaysia)

WHO Secretariat

  • Bernadette Abela-Ridder (NTD)
  • Micha Nuebling (EMP)